Clinical Trials on Secondary Hyperaldosteronism

Total 1531 results

Assistance Publique - Hôpitaux de Paris

Completed

Study of Myocardial Interstitial Fibrosis in Hyperaldosteronism (COEURALDO)

Healthy | Essential Hypertension | Primary Hyperaldosteronism | Secondary Hyperaldosteronism

France
Qifu Li
Fu Wai Hospital, Beijing, China

Completed

Primary Aldosteronism In Hypertensive Patients in China (PA-China)

Hyperaldosteronism; Primary | Hypertension Secondary

China
First Affiliated Hospital of Chengdu Medical College

Recruiting

Comparison of Catecholamine Concentrations in Venous Blood During Selective Adrenal Artery Embolization

Primary Aldosteronism | Resistant Hypertension | Secondary Hypertension | Secondary Hypertension to Endocrine Disorders

China
Uppsala University
Uppsala-Örebro Regional Research Council

Completed

Screening for Primary Aldosteronism in a Population of Patients With Hypertension (PRIMAL)

Hypertension | Primary Aldosteronism | Hypertension Secondary

Sweden
Haukeland University Hospital

Completed

Intraoperative Analysis of Cortisol During Adrenal Vein Sampling

Primary Hyperaldosteronism

Norway
Brigham and Women's Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

Electronic Alert to Improve Testing For Primary Aldosteronism in Patients With Hypertension (ALERT-PA)

Hypertension | Primary Aldosteronism | Hyperaldosteronism | Resistant Hypertension | Mineralocorticoid Excess | Secondary Hypertension

United States
University of Erlangen-Nürnberg Medical School

Recruiting

Tissue K+ in Primary Hyperaldosteronism

Primary Hyperaldosteronism | Electrolyte Disturbance

Germany
University Hospital, Caen

Recruiting

Determination of Threshold Values of Aldosterone in HPLC-MS/MS, of Renin and of the Aldosterone / Renin Ratio for the Diagnosis of Primary Hyperaldosteronism (DAPS)

Hyperaldosteronism; Primary

France
Radboud University Medical Center

Completed

Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment (PAGODE)

Primary Aldosteronism | Primary Hyperaldosteronism

Netherlands
Novartis

Completed

Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism

Primary Hyperaldosteronism

France
University College, London
University College London Hospitals; Cambridge University Hospitals NHS Foundation... and other collaborators

Completed

Radiofrequency Endoscopic Ablation With Ultrasound Guidance: a Non-surgical Treatment for Aldosterone-producing Adenomas (FABULAS)

Primary Hyperaldosteronism | Primary Hyperaldosteronism Due to Adrenal Adenoma

United Kingdom
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Recruiting

Effect of Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling in Primary Aldosteronism

Primary Aldosteronism | Aldosterone-Producing Adenoma | Idiopathic Hyperaldosteronism

China
Imperial College London
Dr Katrina Ohla, Institute of Neuroscience and Medicine, Julich, Germany

Unknown

Investigating Salt Taste Threshold in Patients Being Investigated for Primary Hyperaldosteronism Before and After Treatment. (AldoSalt)

Hypertension | Hyperaldosteronism; Primary | Salt; Excess | Appetite Disorders

United Kingdom
Radboud University Medical Center

Completed

Primary Hyperaldosteronism and Ischemia-reperfusion Injury (PHA-FMD)

Primary Hyperaldosteronism

Netherlands
Helsinki University Central Hospital
Turku University Hospital; Tampere University

Completed

11C-Metomidate PET Versus Adrenal Vein Sampling in Primary Aldosteronism (MIA)

Primary Hyperaldosteronism

Finland
The Second Hospital of Nanjing Medical University

Recruiting

Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism

Secondary Hyperparathyroidism;Parathyroidectomy

China
Université de Sherbrooke
Foundation of the Stars

Recruiting

HyperAldosteronism in Pregnancy Predicted Impacts (H.A.P.P.I. Trial)

Primary Hyperaldosteronism | Hypertensive Disorder of Pregnancy

Canada
Chang Gung Memorial Hospital

Completed

Pulmonary Function, Voice and Swallowing Symptoms After Parathyroidectomy

Secondary Hyperparathyroidism Due to Renal Causes

Taiwan
Fundación Senefro
AbbVie; Effice Servicios Para la Investigacion S.L.

Completed

Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation. (PARIDOINAL)

Secondary Hyperparathyroidism Due to Renal Causes

Spain
Phramongkutklao College of Medicine and Hospital

Completed

Effectiveness of Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients.

Alfacalcidol, Secondary Hyperparathyroidism, Hemodialysis
Haukeland University Hospital
Oslo University Hospital; University Hospital of North Norway; Helse Stavanger... and other collaborators

Recruiting

Primary Aldosteronism in Western Norway

Hyperaldosteronism

Norway
Chinese Academy of Medical Sciences, Fuwai Hospital

Unknown

Adrenal Venous Sampling Via an Antecubital Approach (AVSA)

Hyperaldosteronism | Angiography

China
National Taiwan University Hospital

Unknown

Postoperative Cardiovascular Index Change of Primary Aldosteronism (TAIPAI)

Aldosteronism
Chinese Academy of Medical Sciences, Fuwai Hospital

Not yet recruiting

China National Study of Adrenal Venous Sampling (CNAVS)

Hyperaldosteronism

China
Chinese Academy of Medical Sciences, Fuwai Hospital

Recruiting

Antecubital Versus Femoral Approach for Adrenal Venous Sampling (AFAVS)

Hyperaldosteronism

China
National Taiwan University Hospital

Completed

Kallikrein-kinin (KKS) and Renin-angiotensin-aldosterone System (RAAS) in Primary Aldosteronism

Hyperaldosteronism

Taiwan
Shanghai Zhongshan Hospital

Unknown

Preemptive and Precise Intervention for CKD-SHPT

Hyperparathyroidism; Secondary, Renal
Queen Mary University of London
National Institute for Health Research, United Kingdom; WBIC), Cambridge. University... and other collaborators

Unknown

IS Metomidate PET-CT Superior to Adrenal Venous Sampling in Predicting Outcome From Adrenalectomy in Patients With Primary Hyperaldosteronism (MATCH)

Primary Aldosteronism | Hyperaldosteronism

United Kingdom
Centre Hospitalier Universitaire, Amiens

Completed

Long-term Blood Pressure Outcome After Unilateral Adrenalectomy for Primary Hyperaldosteronism (Hyperaldo)

Adrenalectomy; Status
China-Japan Friendship Hospital

Recruiting

Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

China
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin China Pharmaceutical Co., LTD.; Kyowa Kirin Korea Co., Ltd.

Completed

Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia

Secondary Hyperparathyroidism

China, Hong Kong, Korea, Republic of, Taiwan
Hospital General Ajusco Medio

Completed

IOPTH Usefulness for Predicting Successful Surgery in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

Mexico
Kyowa Kirin Co., Ltd.

Completed

Phase 3 Study of KHK7580

Secondary Hyperparathyroidism

Japan
Kumamoto University

Completed

Maintenance Vitamin D Therapy for Secondary Hyperparathyroidism (2HPT)

Secondary Hyperparathyroidism

Japan
Kyowa Kirin Co., Ltd.

Completed

Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis

Secondary Hyperparathyroidism

Japan
Federal University of Pelotas

Active, not recruiting

Caries Cognition and Identification in Adults (CaCIA)

Secondary Caries

Brazil
Jazz Pharmaceuticals

Approved for marketing

EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML (401)

Secondary AML

United States
Shanghai Hengrui Pharmaceutical Co., Ltd.

Active, not recruiting

A Study of SHR6508 in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

China
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Phase 3 Study of SK-1403

Secondary Hyperparathyroidism

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

SK-1403 Long-term Treatment Study; Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis

Secondary Hyperparathyroidism

Japan
Deltanoid Pharmaceuticals

Completed

A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

United States
Kyowa Kirin Co., Ltd.

Completed

Phase 3 Study of KHK7580

Secondary Hyperparathyroidism

Japan
KAI Pharmaceuticals

Completed

Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

United States
Penang Hospital, Malaysia
Ministry of Health, Malaysia

Unknown

Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients

Secondary Hyperparathyroidism

Malaysia
Seoul National University Hospital
Jeil-Kirin Pharmaceutical Inc.

Completed

Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH Level (CUPID)

Secondary Hyperparathyroidism

Korea, Republic of
University Malaysia Sarawak

Recruiting

Establishment of Aldosterone and Renin Reference Range (ARR)

Aldosteronism

Malaysia
Abbott

Completed

Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis

Secondary Hyperparathyroidism | Dialysis

Mexico
Abbott
Statistika Consultoria Ltda

Terminated

Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects

Secondary Hyperparathyroidism | Dialysis

Brazil
Cairo University

Unknown

Reliability of Secondary Caries Detection Around Composite Restoration Using Light Induced Fluorescence

Secondary Caries

Egypt
Qifu Li
Xiangya Hospital of Central South University; West China Hospital; Tongji Hospital and other collaborators

Recruiting

Outcome of 68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Primary Aldosteronism (GAPA)

Primary Aldosteronism

China

Clinical Trials on Secondary Hyperaldosteronism

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations